Advertisement

Topics

Human medicines European public assessment report (EPAR): Zinbryta, daclizumab, Revision: 3, Authorised

08:30 EDT 5 Jul 2017 | European Medicines Agency

This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Zinbryta, daclizumab, Revision: 3, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zinbryta, daclizumab, Revision: 3, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement